Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PRHSX vs. PHLAX: which is better?

Bottom line

PRHSX vs PHLAX: the short answer

PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and PHLAX (PGIM Jennison Health Sciences Fund) share a meaningful slice of their top holdings — about 52% by weight.

But PRHSX is far broader, holding 279 positions to 55 for PHLAX, so beyond the top names it adds exposure PHLAX doesn't have.

PRHSX is cheaper at 0.83% vs 1.15% — a difference of $32 a year per $10,000 invested.

Over five years, PHLAX returned +5.5% a year vs +4.2% for PRHSX (reporting dates differ).

PHLAX has a front-end sales load of up to 5.5%; the other does not.

Updated Nov 19, 2026

PRHSX vs PHLAX side by side

PRHSXPHLAX
TypeMutual fundMutual fund
Fund familyT. Rowe PricePGIM (Prudential)
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.83%1.15%
Annual cost per $10k$83$115
10-yr cost on $10k (prospectus)$1,025$1,871
Max front load—5.5%
12b-1 fee—0.3%
1-yr return+17.7%+12.7%
5-yr return (annualized)+4.2%+5.5%
10-yr return (annualized)+9.1%+8.9%
Best quarter+23.5%—
Worst quarter−15.8%—
Net assets (fund)$11.9B$1.4B
Number of holdings27955
Portfolio turnover62%81%
Returns as ofDec 31, 2025Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

9 of PRHSX's top 25 holdings also appear in PHLAX's top 25.

Shared top holdings
HoldingPRHSXPHLAX
Eli Lilly & Co14.28%17.35%
Unitedhealth Group Inc5.99%5.87%
Merck & Co. Inc.4.01%6.06%
Thermo Fisher Scientific Inc2.52%4.56%
Vertex Pharmaceuticals Inc2.28%3.37%
Intuitive Surgical Inc1.87%3.07%
Stryker Corp1.78%2.16%
Danaher Corp1.43%3.28%
Cvs Health Corp0.94%2.52%

Source: SEC Form N-PORT

PRHSX top 10

  1. Eli Lilly & Co — 14.28%
  2. Johnson & Johnson — 6.63%
  3. Unitedhealth Group Inc — 5.99%
  4. Abbvie Inc — 5.10%
  5. Merck & Co. Inc. — 4.01%
  6. Gilead Sciences Inc — 2.82%
  7. Thermo Fisher Scientific Inc — 2.52%
  8. Vertex Pharmaceuticals Inc — 2.28%
  9. Bristol-myers Squibb Co — 2.11%
  10. Abbott Laboratories — 1.89%

PHLAX top 10

  1. Eli Lilly & Company — 17.35%
  2. Merck & Company Inc — 6.06%
  3. Unitedhealth Group Inc — 5.87%
  4. Thermo Fisher Scientific Inc — 4.56%
  5. Argenx Se — 3.55%
  6. Vertex Pharmaceuticals Inc — 3.37%
  7. Danaher Corp — 3.28%
  8. Intuitive Surgical Inc — 3.07%
  9. Lonza Group Ag — 3.02%
  10. Cvs Health Corp — 2.52%

FAQ

What is the difference between PRHSX and PHLAX?
PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and PHLAX (PGIM Jennison Health Sciences Fund) share a meaningful slice of their top holdings — about 52% by weight. But PRHSX is far broader, holding 279 positions to 55 for PHLAX, so beyond the top names it adds exposure PHLAX doesn't have.
Which is cheaper, PRHSX or PHLAX?
PRHSX has the lower expense ratio (0.83%).
Should I own both PRHSX and PHLAX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.